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1. Introduction 
In hepatocytes a stream of endocytic vesicles 
moves rapidly from the sinusoidal surface to the cyto- 
plasm in the region of the bile canaliculus. The vesi- 
cles carry polymeric IgA or the haptoglobin-haemo- 
globin complex if these are available in the blood 
[l-4]. The rapid concentration in a particular region 
of cytoplasm suggests that cytoskelktal elements may 
be involved. Accordingly we have examined the 
effects of the microtubule-disruptive drug, colchicine, 
on the transport of IgA across hepatocytes. 
Transportation of IgA across hepatocytes involves 
at least 4 separate processes which could require 
participation of microtubules. 
(1) Before uptake of IgA can take place, the receptor 
for IgA, the glycoprotein secretory component, 
which is synthesised in hepatocytes [5], must 
itself reach the sinusoidal plasma membrane [6]. 
Such movement of glycoproteins from the Golgi 
apparatus to the plasma membrane is inhibited 
by colchicine although glycoprotein synthesis is 
unaffected [7]. 
(2) However, if this were the only point of interfer- 
ence, the secretory component already on the 
membrane before the addition of colchicine 
would be expected to continue to transfer any 
IgA available to it, and also continue to move to 
the bile on its own [4]. The actual formation of 
endocytic vesicles is unlikely to be inhibited 
since in [8] the movement of the plasma mem- 
brane enzyme 5’-nucleotidase into the interior of 
the cell was unaffected by colchicine. 
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(3) The next stage in the transfer process, the rapid 
movement of shuttle vesicles from the sinusoidal 
plasma membrane to the pericanalicular cyto- 
plasm, might well be inhibited. The secretory 
component which was on the sinusoidal plasma 
membrane at the time of colchicine addition 
might not transfer into bile. 
(4) Finally, the release of material from the vesicles 
into the bile might be inhibited. 
We now report that colchicine appears to inhibit both 
the movement of secretory component from the 
Golgi apparatus to the sinusoidal plasma membrane 
and the movement of secretory IgA and of free secre- 
tory component to the pericanalicular cytoplasm in 
the isolated perfused rat liver. 
2. Materials and methods 
Liver perfusion experiments were performed as in 
[4]. C[4,5-3H] Leucine (160 mCi/mmol) was obtained 
from the Radiochemical Centre (Amersham, Bucks). 
Colchicine, obtained from Sigma (London) was 
added to the perfusion medium to give 50 E.~M 
final cont., which has been shown to be in the 
middle of the concentration range for maximal inhib- 
ition of plasma protein release and asialoglycoprotein 
uptake and degradation [7,9]. Protein synthesis and 
nucleotide phosphate levels are not affected [7]. Rat 
monoclonal polymeric IgA was prepared and labelled 
with “‘1 as in [2]. 12’1 in bile samples was counted 
directly on a PRIAS liquid scintillation counter 
(Packard Instruments, Downers Grove, IL). Acid-pre- 
cipitable 3H in the perfusion medium was determined 
and crossed immunoelectrophoresis of bile samples 
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against anti(rat bile) carried out as in [lo]. Free 
secretory component, which is electrophoretically 
faster moving than secretory IgA, and albumin in 
bile were estimated from the areas of the appropriate 
peaks on the crossed immunoelectrophoresis plates. 
IgA in bile samples was assayed by rocket immuno- 
electrophoresis [ 1 l] in gels containing an antiserum 
to rat IgA heavy chain [ 121. 
3. Results 
Rat livers perfused with media containing radio- 
active precursors steadily secrete labelled proteins 
into the medium 141. As expected [7] the rate of this 
secretion was reduced after addition of colchicine to 
the medium (fig.la). 
The transport of 1251-labelled IgA from the perfu- 
sion medium to bile resembled that seen in the intact 
animal [ 121 with an initial lag period of -30 min 
followed by a steady rise. Recovery of ‘251-labelled 
IgA in the bile did not approach that seen in intact 
animals [ 121 presumably because the IgA level in the 
relatively large volume of perfusion medium remained 
relatively steady unlike the serum level in the intact 
animal. The amount of IgA added was insufficient to 
saturate the transport system and a further addition 
of IgA 3 h after the first produced a further rise in 
the radioactivity of bile after the characteristic 30 
min lag (fig.lb). 
Addition of colchicine to the medium 15 min 
before addition of labelled IgA greatly reduced the 
initial rise in biliary radioactivity and almost obliter- 
ated the rise after the second addition of IgA (fig.lb). 
In a similar experiment (not shown) where colchicine 
was added between the doses of IgA, the rise in activ- 
ity in the bile after the second addition of IgA was 
prevented in a liver which had already shown a nor- 
mal ability to transport IgA. 
The amount of free secretory component per 
unit volume of bile from normal perfused livers rose 
with time (fig.2) since only negligible amounts of 
secretory component were reaching bile as secretory 
IgA. Addition of colchicine caused an immediate 
drop in the amounts of free secretory component 
appearing in the bile and, if added early in the perfu- 
sion, prevented any rise (fig.2). Levels of major serum 
proteins, exemplified by albumin, per unit volume of 
bile remained steady in the absence of colchicine. 
About 1 h after colchicine addition however, levels 
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Fig.1. Effects of 50 PM colchicine following the addition of 
L-[4,5-“Hlleucine or I” I&belled IgA to the recirculating 
perfusion medium supplied to isolated rat livers on the 
appearance of (a) acid-precipitable [sH]leucine in perfusion 
medium and (b) ‘ZSI-labelled IgA in bile. Radioactivity is 
plotted against ime after addition of the isotopically labelled 
compound to the medium. A second addition of ‘2SI-labelled 
IgA was made at the times marked. Each line shown illustrates 
an experiment on a single liver but similar results were 
obtained on at least two livers In each case. (a) Colchicine 
was added at the time indicated; (b) (0) no colchicine, (0) 
colchicine added 15 min before ‘asl-labelled IgA. 
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Fig.2. Effects of 50 PM colchicine on amounts of free secre- 
tory component and albumin appearing in bile from isolated 
rat livers. Amounts of secretory component (closed symbols) 
and albumin (open symbols) in arbitrary units are plotted 
against ime after cannulation of the bile duct. Each line 
shown illustrates an experiment on a single liver but similar 
results were obtained on at least two livers in each case. 
(A . . . . . *... a) No colchicine; (o-o, o-o) colchicine 
added after 160 min; (u-.-.a, o-.--o) colcbicine added as 
soon as the liver was established in the perfusion apparatus 
(60 min). 
of albumin (and other serum proteins) began to rise 
slowly (fig.2). 
The release of vesicles from the pericanalicular 
space into the bile was examined by measuring the 
rate of the fall in biliary IgA levels with time after 
removal of the liver from the rat. Initially the vesicles 
in the pericanalicular space will be loaded with IgA. 
When the liver is removed from the rat the IgA supply 
is cut off and vesicles reaching the pericanalicular 
cytoplasm thereafter will have little or no IgA. Fig.3 
shows that the fall in bihary IgA levels is apparently 
unaffected by the presence of colchicine. 
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Fig.3. Effect of colcbicine on amounts of IgA appearing in 
bile from isolated rat livers. Amounts of IgA in arbitrary 
units are plotted on a logarithmic scale against ime after 
cannulation of the bile duct. (a) No colcbicine; (b) colchicine 
added as soon as the liver was established into the perfusion 
apparatus: bile collection for the first point began immedi- 
ately. The results of two independent experiments are 
illustrated in each half of the diagram. (o-o, n . . .=) Nor- 
mal livers, P2 37 and 32 (min); (A . . . A, ~--a) colchicine- 
treated livers, t”’ 37 and 30 (min). 
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4. Discussion 
Colchicine clearly inhibits the transfer of 1251- 
labelled IgA from blood to bile, it would therefore 
appear that microtubules are important in at least 
some part of this process. As described in section 1, 
colchicine might interfere with the process at several 
points. The release of IgA from the pericanalicular 
cytoplasm into the bile, the transfer of endocytic 
shuttle vesicles carrying secretory IgA and free secre- 
tory component and the supply of secretory compo- 
nent to the sinusoidal plasma membrane might each 
or all be affected by colchicine. An effect on endo- 
cytic vesicle formation is unlikely [S]. 
From our results it appears that colchicine has no 
effect on the final part of the process, i.e., the release 
from endocytic vesicles of secretory IgA into bile. 
Fig.3 indicates that in both normal and colchicine- 
treated liver the release of IgA was a first order reac- 
tion with random release of the contents of endocytic 
shuttle vesicles waiting near the bile canalicular 
plasma membrane [ 11. 
Colchicine would, however, appear to inhibit the 
movement of endocytic vesicles from the sinusoidal 
plasma membrane to the bile canalicular plasma mem- 
brane. As pointed out in section 1, if only the trans- 
port of secretory component to the sinusoidal plasma 
membrane were inhibited, the secretory component 
already on the plasma membrane should move to the 
bile in the normal way taking -30 min. to do so. 
However, measurements of the amount of free secre- 
tory component in the bile (fig.2) showed that the 
steady rise seen in normal livers (due to only trace 
amounts of IgA with which to combine) was imme- 
diately stopped by the addition of colchicine and 
levels of free secretory component thereafter begin to 
fall. We conclude that the rapid movement of endo- 
cytic shuttle vesicles depends on intact microtubules. 
A similar conclusion was reported from an immuno- 
electron microscopic study of the movement of IgA- 
containing vesicles across cultured human neoplastic 
colon cells [ 131. 
The movement of shuttle vesicles from sinusoidal 
to bile canalicular plasma membranes was not com- 
pletely inhibited in colchicine-treated livers since 
some labelled IgA appears in bile even when colchi- 
tine is added beforehand (fig.lb). Such partial inhibi- 
tion by colchicine (-60%) is in accordance with 
results on both secretion [7] and endocytosis [9,14] 
in hepatocytes. 
The time course of the appearance of labelled IgA 
in the bile from a colchicine-treated liver suggests that 
the supply of secretory component to the sinusoidal 
plasma membrane was inhibited in addition to the 
inhibition of endocytic vesicle movement. Initially, 
when the sinusoidal plasma membrane was loaded 
with secretory component, amounts of IgA appearing 
in bile whilst clearly subnormal, did increase (fig. 1 b). 
However, -90 min after colchicine addition, amounts 
of labelled IgA reaching the bile began to fall and a 
second addition of labelled IgA produced little res- 
ponse. It appears likely, then, that colchicine inhibits 
the supply of free secretory component to the 
sinusoidal plasma membrane, the amounts of labelled 
IgA reaching bile falling off as soon as the secretory 
component initially present on the plasma membrane 
has been used up. Such an inhibition resembles that 
seen for plasma protein secretion [7]. 
Microtubules would thus appear to be required 
both for the rapid and specific transfer of free secre- 
tory component from the Golgi region to the sinus- 
oidal plasma membrane and for the movement of 
endocytic vesicles from the region of the sinusoidal 
surface to the region of the bile canalicular surface 
of the cell. Such involvement of microtubules in the 
rapid movement of membraneous vesicles both to 
and from a surface could be similar to that observed 
in nerve cells [15]. 
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